Anthropic has launched Claude Science, a new AI research workbench aimed at pharmaceutical research, marking a significant vertical integration into the life sciences sector. This move is bolstered by
Takeda has announced a strategic collaboration with Insilico Medicine, a leader in generative AI for drug discovery, to advance drug candidates across its therapeutic areas. The deal includes a $60 mi
Anthropic has launched Claude Science, an AI workbench specifically designed for pharmaceutical researchers, aiming to automate and accelerate drug discovery processes. The new product is intended to
The convergence of artificial intelligence (AI) and organoid technology is significantly advancing precision and predictive medicine. This integration offers physiologically relevant 3D models and lev
Takeda has entered a strategic collaboration with Insilico Medicine to utilize its AI-based Pharma.AI platform for the discovery and development of novel drug candidates across Takeda's therapeutic ar
Researchers have successfully used ultrasound and artificial intelligence to guide algae microrobots in delivering chemotherapy deep into tumors in mice. This innovative approach shows promise for imp